Author:
Inoue Kyoichi,Konda Takehiko,Takashima Kiyotsugu,Kuwabara Yoshihiro,Sasaki Hiroshi
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Alter HJ, Holland PV, Purcell RH, et al: Posttransfusion hepatitis after exclusion of commercial and hepatitis B antigenpositive donors. Ann Intern Med 1972;77: 691–699
2. Seeff LB, Wright EC, Zimmerman HJ, et al: VA cooperative study of post-transfusion hepatitis, 1969–1974: incidence and characteristics of hepatitis and responsible risk factors. Am J Med Sci 1975;270: 355–362
3. Katayama T: Posttransfusion hepatitis in Japan In: Report of research committee on post transfusion hepatitis (Chairman Mayumi T) Japan Red Cross, Tokyo 1988; 297–308 (In Jpn)
4. Shimizu S, Ohyama M, Takahashi Y, et al: Immunoglobulin M antibody against hepatitis B core antigen for diagnosis of fulminant type B hepatitis. Gastroenterology 1983;84: 604–610
5. Sugg U. Erhardt S, Morgenroth T, et al: Is the use of the term “posttransfusion hepatitis type B” in its conventional sense still justifiable. Vox Sang, 1983;44: 305–311